Olmetec (Olmesartan Medoxomil)

Olmesartan medoxomil, the active ingredient in Olmetec, is an angiotensin II receptor blocker presented as a tablet for oral use. It is indicated for the management of hypertension in adults. GNH USA supplies Olmetec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmetec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxomil is used to treat high blood pressure by blocking the renin‑angiotensin system.

- Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: helps slow progression of kidney damage associated with diabetes.

Olmesartan medoxil may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Diarrhea - Cough

Serious or Rare Side Effects: - Angio‑edema - Hyperkalemia - Acute kidney injury - Severe hypotension - Liver enzyme elevation - Bullous pemphigoid

Olmesartan medoxomil should be used with caution in several 

- Monitor  :       "); -  ");\n"); "); ",

Sorry  t…